Correlation Between Verastem and Syros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Verastem and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verastem and Syros Pharmaceuticals, you can compare the effects of market volatilities on Verastem and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Syros Pharmaceuticals.

Diversification Opportunities for Verastem and Syros Pharmaceuticals

-0.62

Correlation Coefficient

Verastem  Syros Pharmaceuticals

Excellent diversification

The 3 months correlation between Verastem and Syros is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Verastem i.e., Verastem and Syros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Verastem and Syros Pharmaceuticals

Given the investment horizon of 90 days Verastem is expected to generate 0.49 times more return on investment than Syros Pharmaceuticals. However, Verastem is 2.03 times less risky than Syros Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest  367.00  in Verastem on December 28, 2024 and sell it today you would earn a total of  252.00  from holding Verastem or generate 68.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	93.44%
Values	Daily Returns

Verastem  vs.  Syros Pharmaceuticals

Verastem

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.

Syros Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Syros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Verastem and Syros Pharmaceuticals

The main advantage of trading using opposite Verastem and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.

The idea behind Verastem and Syros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.